1085155

SpecGx, LLC — FEI 3005275960

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 6, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Webster Groves, MO (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)